Condition: Chemotherapy-Related Nausea and/or Vomiting · Early Stage Breast Carcinoma · Anatomic Stage I Breast Cancer AJCC v8 · Sponsor: Mayo Clinic
This pilot study seeks to understand how changes in the bacteria composition (microbiome) of the gut may be associated with the occurrence of fatigue and chemotherapy-induced nausea (CIN) in women undergoing chemotherapy for early stage breast cancer. Patients undergoing chemotherapy may experience fatigue or nausea as a result of their treatment. Known risk factors for fatigue and CIN do not explain the differences in fatigue and CIN occurrence between patients, but changes in the functions of the gut microbiome may be related to the occurrence of fatigue and CIN. This study collects stool samples from breast cancer patients before and after chemotherapy to evaluate how changes in the microbiome may be associated with fatigue and CIN.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Arizona | Scottsdale, Arizona, United States | Suspended |
| Mayo Clinic in Florida | Jacksonville, Florida, United States | Active Not Recruiting |
| Mayo Clinic Health System in Albert Lea | Albert Lea, Minnesota, United States | Recruiting |
| Mayo Clinic Health System in Mankato | Mankato, Minnesota, United States | Recruiting |
| Mayo Clinic in Rochester | Rochester, Minnesota, United States | Suspended |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05417867